Cargando…

A comparative public health and budget impact analysis of pneumococcal vaccines: The French case

In 2002, a pneumococcal conjugate vaccine (PCV) was introduced to French infants and toddlers. A change has been witnessed in the incidence of pneumococcal diseases in adults: the incidence of invasive pneumococcal disease (IPD) of serotypes covered by PCV decreased, and serotypes not covered by PCV...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Yiling, Gervais, Frédéric, Gauthier, Aline, Baptiste, Charles, Martinon, Prescilla, Bresse, Xavier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635706/ https://www.ncbi.nlm.nih.gov/pubmed/26267239 http://dx.doi.org/10.1080/21645515.2015.1011957

Ejemplares similares

Cost-Effectiveness and Budget Impact Analyses of Pneumococcal Vaccination in Indonesia
por: Suwantika, Auliya A., et al.
Publicado: (2021)

Pneumococcal conjugate vaccination in The Gambia: health impact, cost effectiveness and budget implications
por: Pecenka, Clint, et al.
Publicado: (2021)

A comparative analysis of the epidemiological impact and disease cost-savings of HPV vaccines in France
por: Bresse, Xavier, et al.
Publicado: (2013)

Nutrition-Related Mobile Apps in the French App Stores: Assessment of Functionality and Quality
por: Martinon, Prescilla, et al.
Publicado: (2022)

Association of Pneumococcal Conjugate Vaccine Coverage With Pneumococcal Meningitis: An Analysis of French Administrative Areas, 2001–2016
por: Alari, Anna, et al.
Publicado: (2019)

Oral-Hygiene-Related Mobile Apps in the French App Stores: Assessment of Functionality and Quality
por: Carrouel, Florence, et al.
Publicado: (2022)

Role of vaccination in the sustainability of healthcare systems
por: Largeron, Nathalie, et al.
Publicado: (2015)

Promoting Health via mHealth Applications Using a French Version of the Mobile App Rating Scale: Adaptation and Validation Study
por: Saliasi, Ina, et al.
Publicado: (2021)

Public Budgeting in Context
por: Willoughby, Katherine
Publicado: (2014)

Loss of chance associated with sub-optimal HPV vaccination coverage rate in France
por: Uhart, Mathieu, et al.
Publicado: (2017)

Budget impact analysis of a pneumococcal vaccination programme in the 65-year-old Spanish cohort using a dynamic model
por: Pradas, Roberto, et al.
Publicado: (2013)

Impact of pneumococcal vaccines use on invasive pneumococcal disease in Nunavik (Quebec) from 1997 to 2010
por: Le Meur, Jean-Baptiste, et al.
Publicado: (2014)

Budget Impact Analysis of Expanding Gliflozin Coverage in the CKD Population: A French Perspective
por: de Pouvourville, Gérard, et al.
Publicado: (2023)

Changes in epigenetic profiles throughout early childhood and their relationship to the response to pneumococcal vaccination
por: Pischedda, Sara, et al.
Publicado: (2021)

Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe
por: Marty, Rémi, et al.
Publicado: (2013)

French Hajj pilgrims' experience with pneumococcal infection and vaccination: A knowledge, attitudes and practice (KAP) evaluation
por: Sridhar, Shruti, et al.
Publicado: (2015)

Comparison of the Impact of Pneumococcal Conjugate Vaccine 10 or Pneumococcal Conjugate Vaccine 13 on Invasive Pneumococcal Disease in Equivalent Populations
por: Naucler, Pontus, et al.
Publicado: (2017)

Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease
por: Melegaro, Alessia, et al.
Publicado: (2010)

Assessing Public Health Impact of Four Pediatric Pneumococcal Conjugate Vaccination Strategies in the Netherlands
por: Wilson, Michele, et al.
Publicado: (2023)

Estimating the Public Health and Economic Impact of Introducing the 13-Valent Pneumococcal Conjugate Vaccine or 10-Valent Pneumococcal Conjugate Vaccines into State Immunization Programs in India
por: Ghia, Canna J., et al.
Publicado: (2021)

Projected impact, cost-effectiveness, and budget implications of rotavirus vaccination in Mongolia
por: Lusvan, Munkh-Erdene, et al.
Publicado: (2019)

Global Control of Pneumococcal Infections by Pneumococcal Vaccines
por: Oishi, Kazunori, et al.
Publicado: (2014)

Pneumococcal disease and use of pneumococcal vaccines in Taiwan
por: Wei, Sung-Hsi, et al.
Publicado: (2015)

Correction to: Budget Impact Analysis of Fidaxomicin Versus Vancomycin for the Treatment of Clostridioides difficile Infection in the United States
por: Jiang, Yiling, et al.
Publicado: (2022)

POSC117 A Public Health and Budget Impact Analysis (BIA) of COVID-19 Vaccination in Austria
por: Traunfellner, M, et al.
Publicado: (2022)

Budget Impact of Publicly Reimbursed Prescription Medicines in the Republic of Srpska
por: Petrusic, Tamara, et al.
Publicado: (2015)

Systematic review of cost-effectiveness analyses for combinations of prevention strategies against human papillomavirus (HPV) infection: a general trend
por: Gervais, Frédéric, et al.
Publicado: (2017)

Response to pneumococcal vaccination in multiple myeloma
por: Renaud, Loïc, et al.
Publicado: (2019)

Correction to: Estimating the Public Health and Economic Impact of Introducing the 13-Valent Pneumococcal Conjugate Vaccine or 10-Valent Pneumococcal Conjugate Vaccines into State Immunization Programs in India
por: Ghia, Canna J., et al.
Publicado: (2021)

Recent Topics of Pneumococcal Vaccination: Indication of Pneumococcal Vaccine for Individuals at a Risk of Pneumococcal Disease in Adults
por: Asai, Nobuhiro, et al.
Publicado: (2021)

Exploring the evidence behind the comparable impact of the pneumococcal conjugate vaccines PHiD-CV and PCV13 on overall pneumococcal disease
por: Izurieta, Patricia, et al.
Publicado: (2021)

Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to the 23-valent pneumococcal polysaccharide vaccine in elderly Japanese adults
por: Shiramoto, Masanari, et al.
Publicado: (2015)

Impact of Pneumococcal Conjugate Universal Routine Vaccination on Pneumococcal Disease in Italian Children
por: Fortunato, Francesca, et al.
Publicado: (2015)

Impact of national pneumococcal vaccination program on invasive pneumococcal diseases in South Korea
por: Jung, Yeon Haw, et al.
Publicado: (2022)

The impact of introduction of the 10-valent pneumococcal conjugate vaccine on pneumococcal carriage in Nigeria
por: Adamu, Aishatu L., et al.
Publicado: (2023)

Public health and budget impacts of switching from a trivalent to a quadrivalent inactivated influenza vaccine in Paraguay
por: Arbo, Antonio, et al.
Publicado: (2022)

Health and economic outcomes of 20-valent pneumococcal conjugate vaccine compared to 15-valent pneumococcal conjugate vaccine strategies for adults in Greece
por: Gourzoulidis, George, et al.
Publicado: (2023)

Pneumococcal responses are similar in Papua New Guinean children aged 3-5 years vaccinated in infancy with pneumococcal polysaccharide vaccine with or without prior pneumococcal conjugate vaccine, or without pneumococcal vaccination
por: van den Biggelaar, Anita H. J., et al.
Publicado: (2017)

The remarkable history of pneumococcal vaccination: an ongoing challenge
por: Musher, Daniel M., et al.
Publicado: (2022)

Budgeting of non-commercial clinical trials: development of a budget tool by a public funding agency
por: Nevens, Hilde, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7dh4d5dqldp5g4c0ddurccg8uv